Anuh Pharma Limited's 65th Annual General Meeting successfully adopted the audited financial statements for FY25. Shareholders approved a dividend of Rs. 1.50 per equity share for FY24-25. Key resolutions included the re-appointment of directors Mr. Bharat Nemchand Shah and Mr. Gaurav Satish Shah, and the ratification/appointment of Cost and Secretarial Auditors. Importantly, shareholders also approved revisions in remuneration for Joint Managing Directors Mr. Ritesh B. Shah and Mr. Vivek Shah for FY25-26, and their re-appointment for five years starting January 2026.